Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Artificial Organs|May 8, 2010
Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndromeIoannis Griveas, George Visvardis, Dorothea Papadopoulou, et al.
International Urology and Nephrology|September 6, 2005
Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochlorideEfstathios Mitsopoulos, Ioannis Griveas, Stavros Zanos, et al.
The International Journal of Artificial Organs|March 17, 2018
HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?Nikolaos Papadopoulos, Ioannis Griveas, Eirini Sveroni, et al.
Artificial Organs|August 19, 2011
Osmolal gap in hemodialyzed uremic patientsIoannis Griveas, Athina Gompou, Ilias Kyritsis, et al.
Renal Failure|August 25, 2006
Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzersIoannis Griveas, George Visvardis, George Sakellariou, et al.
Renal Failure|November 6, 2004
Therapeutic apheresis of immune diseases in nephrology departmentGeorge Visvardis, Eleni Manou, Ioannis Griveas, et al.
Renal Failure|June 17, 2005
Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysisIoannis Griveas, George Visvardis, Aleka Fleva, et al.
Renal Failure|June 17, 2005
Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysisIoannis Griveas, G Visvardis, D Papadopoulou, et al.
Renal Failure|August 3, 2005
Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patientsG Visvardis, Ioannis Griveas, A Fleva, et al.
Renal Failure|December 17, 2004
Lymphocytes subsets in the course of continuous ambulatory peritoneal dialysis (CAPD)Ioannis Griveas, G Visvardis, A Fleva, et al.
Pageof 4